US Stock MarketDetailed Quotes
ABVC ABVC BioPharma
- 0.6873
- +0.0273+4.14%
Close Sep 27 16:00 ET
- 0.6877
- +0.0004+0.06%
Post 20:01 ET
8.54MMarket Cap-414P/E (TTM)
0.6949High0.6303Low77.88KVolume0.6742Open0.6600Pre Close52.45KTurnover0.81%Turnover RatioLossP/E (Static)12.42MShares3.350052wk High1.03P/B6.58MFloat Cap0.600052wk Low--Dividend TTM9.57MShs Float116.9000Historical High--Div YieldTTM9.79%Amplitude0.6000Historical Low0.6730Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
ABVC BioPharma Stock Forum
ABVC Biopharma- Got Written Notification From Nasdaq, Indicating Co Regained Compliance With Listing Rules 5635(a)(1) and 5635(a)(2)
- Earnings Per Share (EPS): Demonstrated a remarkable year-over-year improvement of approximately 86.8%, with EPS improving to -$0.09 in Q2 2024 from -$0.68 in the same period last year. This significant progress reflects our successful efforts in managing operational expenses and capitalizing on milestone payment revenue from licensing agreements.
- Revenue Growth: Revenue increased to $117,142 in Q2 2024, a substantial rise from $6,109...
$Bright Minds Biosciences (DRUG.US)$ $ABVC BioPharma (ABVC.US)$ $SAI TECH Global (SAI.US)$ $Addentax (ATXG.US)$ $Chuy's Holdings (CHUY.US)$
ABVC Biopharma Inc - Collaboration Between ABVC and Oncox Biopharma, ABVC Expecting Aggregate Income of $13.75 Mln and Royalties of up to $12.50 Mln
Larger Image: tradingview.com...
$ABVC BioPharma (ABVC.US)$
📊⚡️📊
📊⚡️📊
No comment yet